» Articles » PMID: 9355934

Aspirin As a Therapeutic Agent in Cardiovascular Disease: a Statement for Healthcare Professionals from the American Heart Association

Overview
Journal Circulation
Date 1997 Nov 14
PMID 9355934
Citations 59
Authors
Affiliations
Soon will be listed here.
Citing Articles

Polygenic risk, aspirin, and primary prevention of coronary artery disease.

Yu C, Natarajan P, Patel A, Bhatia H, Khera A, Neumann J Eur Heart J Cardiovasc Pharmacother. 2024; 11(1):84-91.

PMID: 39455425 PMC: 11805692. DOI: 10.1093/ehjcvp/pvae085.


Fixed dose combination of aspirin and pantoprazole: Results of a multicenter, comparative, randomized, double-blind, double dummy, phase III study in Indian patients.

Choudhary R, Khan M, Dosi R, Choudhari S, Pawar D, Shahavi V Indian Heart J. 2024; 76(4):280-285.

PMID: 39009075 PMC: 11451355. DOI: 10.1016/j.ihj.2024.07.007.


Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes.

Lacaze P, Bakshi A, Riaz M, Polekhina G, Owen A, Bhatia H J Am Coll Cardiol. 2022; 80(14):1287-1298.

PMID: 36175048 PMC: 10025998. DOI: 10.1016/j.jacc.2022.07.027.


The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study.

Elshafei M, Imam Y, Alsaud A, Chandra P, Parray A, Abdelmoneim M Eur J Clin Pharmacol. 2022; 78(11):1801-1811.

PMID: 36121499 PMC: 9546947. DOI: 10.1007/s00228-022-03391-2.


Safety of Continuous Low-Dose Aspirin Therapy for Cervical Laminoplasty.

Inoue T, Mizutamari M, Hatake K Spine Surg Relat Res. 2022; 6(3):240-246.

PMID: 35800625 PMC: 9200418. DOI: 10.22603/ssrr.2021-0081.